Vivodyne

Vivodyne is replacing animal testing with an exclusively human optimization preclinical process using robotics and AI to test on thousands of lab-grown, fully-functional human tissues. The platform provides clinically relevant human data at a massive scale to reduce trial risk, accelerate drug discovery, and bring safer, more effective therapies to patients faster. Vivodyne's technology is already used by most top pharma companies.

Funding Round: Series A

Funding Amount: $40M

Date: 29-May-2025

Investors: Khosla Ventures, Lingotto Investment Management, Helena Capital, Fortius Ventures, Kairos Ventures, CS Ventures, Bison Ventures, MBX Capital

Markets: Biotech, AI, Healthcare

HQ: San Francisco, California, United States

Founded: 2020

Website: https://vivodyne.com/

LinkedIn: https://www.linkedin.com/company/vivodyne

Twitter: https://twitter.com/vivodyne

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/vivodyne

Pitchbook: https://pitchbook.com/profiles/company/463337-02